The Tailored Biosimilar Approach: Expectations and - PMC
by E Guillen 2025 Cited by 11 In this article, we discuss the tailored biosimilar approach, which represents an evolution in regulatory thinking by moving away from the default requirementRead more
Implementation of the Biosimilar Pathway: Economic and
by H Grabowski 2011 Cited by 64 The European Union has had a well-defined regulatory pathway for biosimilars in place for several years which provides one model that couldRead more
Cookie consent notice
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.